Skip to main content
. Author manuscript; available in PMC: 2020 Dec 15.
Published in final edited form as: Breast Cancer Res Treat. 2019 Mar 26;175(3):755–764. doi: 10.1007/s10549-019-05193-0

Table 1.

Definition of Breast Cancer Cases

Case Type Definition
Inflammatory breast cancer (IBC) Morphology:
2001-2015
 • ICD-O-3 (converted from ICD-O-2 for 1988-2000) = 8530 “Inflammatory Carcinoma”
or Stage:
2001-2015
 • AJCC TNM, T = T4d “Inflammatory Carcinoma”

or Extent of Disease:
2001-2003 (Historic)
 • 70: “Inflammatory carcinoma, including diffuse (beyond that directly overlying the tumor) dermal lymphatic permeation or infiltration.”

2004-2010 (Collaborative Staging)
 • 71: “Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d’ orange, etc., involving not more than 50% of the skin of the breast, or percent of involvement not stated, WITH or WITHOUT dermal lymphatic infiltration. Inflammatory carcinoma, NOS.”
 • 73: “Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d’orange, etc., of more than 50% of the breast, WITH or WITHOUT dermal lymphatic infiltration.”

2011-2015 (Collaborative Staging)
 • 600: “Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d’orange, etc., involving less than one-third (33%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration.”
 • 725: “Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d’orange, etc., involving one-third (33%) or more but less than or equal to one-half (50%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration.”
 • 730: “Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d’orange, etc., involving more than one-half (50%) of the skin of the breast, WITH or WITHOUT dermal lymphatic infiltration.”
 • 750: “Diagnosis of inflammatory carcinoma WITH a clinical description of inflammation, erythema, edema, peau d’orange, etc., but percent of involvement not stated, WITH or WITHOUT dermal lymphatic infiltration. Diagnosis of inflammatory carcinoma WITHOUT a clinical description of inflammation, erythema, edema, peau d’orange, etc., WITH or WITHOUT dermal lymphatic infiltration. Inflammatory carcinoma, NOS.”
 • 780: “Stated as T4d with no other information on extension.”
Non-inflammatory locally advanced breast cancer (LABC) Stage:
2001-2015
Not an IBC case as defined above and:
 • AJCC TNM, T = T4a (extension to the chest wall, not including only pectoralis muscle adherence/invasion), or
 • AJCC TNM, T = T4b (ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin, which do not meet the criteria for inflammatory carcinoma), or
 • AJCC TNM, T = T4c (both T4a and T4b)
Other localized breast cancer SEER Historic Stage A = “localized”
Other regional/distant/unstaged other breast cancer SEER historic stage A = “regional/distant/unstaged”